Demodex Blepharitis

Study Finds Lotilaner Safe, Effective for Demodex Blepharitis at One Year

The drug’s effect may even continue well after completion of therapy, the new data suggests.
02/14/2024

Common OSSN Therapy May Also Treat Demodex Blepharitis

After two cycles of 1% 5-fluorouracil, patients in a small study experienced clinical improvement lasting up to 55 months.
01/23/2024

Ivermectin Cream Effective Against Demodex Blepharitis

A study demonstrated its benefits in reducing the signs of demodicosis, sustained up to one year after the treatment was prescribed.
12/07/2023

Retinoblastoma Survival Depends on Countries’ Incomes

Children in poorer regions were three times more likely to die.
11/13/2023

Tackle MGD with These Hands-on Interventions

Adding gland expression, along with blepharoexoliation and IPL, unlocks new levels of control over patient outcomes. We show you the proper way to go about it.
10/11/2023

Demodex Not Linked to MGD, DED in Patients Over 60

One possible explanation is that this age group’s increased prevalence and severity of mite infestation could have a desensitizing effect on the ocular surface over time, researchers suggest.
10/04/2023

First Prescription Treatment for Demodex Blepharitis Approved

In clinical trials, Xdemvy was able to significantly reduce or eradicate mite infestation in six weeks and showed some improvement within 15 days.
07/25/2023

Study Links Cataract Surgery to Increased Demodex Population

Possibly due to topical steroid use, mite infestation was more common in these patients.
06/01/2023

Experts Agree on Demodex Signs, Symptoms But Not Treatment

The group was evenly split between advocating blepharoexfoliation or tea tree oil.
03/29/2023

Upcoming Events

November 6, 2024

Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm CT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Harry Boparai, OD, and Doug Katsev, MD
Webinar: 7:00pm PT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

The 3 I's of Geographic Atrophy: Imaging, Identification, and Intervention
Location: Virtual
Presenters: Jordana Fein, MD, and Julie Rodman, OD, MS, 
Webinar: 9:30pm ET


Sponsored by Apellis

Register here